Researchers are excited about the medication , a innovative dual agonist showing promising data in early trials for weight reduction . It acts by modulating two hormones : GLP-1 and GIP, that , when https://sabrinabvyz660737.snack-blog.com/40985588/this-new-prospect-for-weight-reduction